
    
      Phase 1 will aim to define a normal endometrial transcriptomic signature in healthy controls
      without infertility. Phase 2 will elucidate endometrial transcriptomic expression in patients
      with diagnoses of infertility unrelated to endometrial factor. Findings from this phase will
      be compared to the results of phase 1.
    
  